NCT00491374View on ClinicalTrials.gov

Study of Nasonex® in Improving Sleep Disturbances Related to Perennial Allergic Rhinitis (Study P04909)(TERMINATED)

PHASE4TerminatedINTERVENTIONAL

0

Timeline

Start Date

September 30, 2006

Study Completion Date

October 31, 2007

Conditions

Perennial Allergic Rhinitis

Interventions

DRUG

Mometasone Furoate Nasal Spray

Nasonex Nasal Spray 50 mcg/spray, 200 mcg (4 sprays) once daily every morning for 28 days.

DRUG

Placebo

Placebo Nasal Spray 4 sprays once daily every morning for 28 days.

Sponsors

Lead Sponsor

Schering-Plough

All Listed Sponsors

lead

Schering-Plough

INDUSTRY